Association between TGFBR2 gene polymorphism (rs2228048, Asn389Asn) and intracerebral hemorrhage in Korean population

Immunological Investigations

Volumn 40, Issue 6, 2011, Pages 569-580

  Lim, Yun Hee ^a   Jeong, Yong Seol ^a   Kim, Su Kang ^a   Kim, Dong Hwan ^a   Yun, Dong Hwan ^a   Yoo, Seung Don ^a   Kim, Hee Sang ^a   Baik, Hyung Hwan ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Intracerebral hemorrhage; Ischemic stroke; Polymorphism; TGFBR2

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CEREBRAL HEMORRHAGE; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPUBLIC OF KOREA; RISK; SMOKING; STROKE;

EID: 79959606547     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.559498     Document Type: Article

References (29)

1. American Heart Association. (2010). Heart Disease and Stroke Statistics-2005 Update. American Heart Association.
2. Baas, A.F., Medic, J., van t Slot, R., de Kovel, C.G., Zhernakova, A., Geelkerken, R.H., Kranendonk, S.E., van Sterkenburg, S.M., Grobbee, D.E., Boll, A.P., Wijmenga, C., Blankensteijn, J.D., Ruigrok, Y.M. (2010). Association of the TGF-beta receptor genes with abdominal aortic aneurysm. Eur. J. Hum. Genet. 18(2):240-244.
3. Gil-Núñez, A. (2007). The metabolic syndrome and cerebrovascular disease: suspicion and evidence. Cerebrovasc. Dis. 24 Suppl 1:64-75. (Pubitemid 350035854)
4. Grysiewicz, R.A., Thomas, K., Pandey, D.K. (2008). Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol. Clin. 26(4):871-895.
5. Gulubova, M., Manolova, I., Ananiev, J., Julianov, A., Yovchev, Y., Peeva, K. (2010). Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Int. J. Colorectal Dis. 25(5):591-599.
6. Ikeda, H. (2005). Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas. Brain Tumor Pathol. 23(1):7-12. (Pubitemid 44576305)
7. Jin, G., Wang, L., Chen, W., Hu, Z., Zhou, Y., Tan, Y., Wang, J., Hua, Z., Ding, W., Shen, J., Zhang, Z., Wang, X., Xu, Y., Shen, H. (2007). Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int. J. Cancer 120(6):1330-1335.
8. Lanktree, M.B., Dichgans, M., Hegele, R.A. (2010). Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41(4):825-382.
9. Li, M.O., Sanjabi, S., Flavell, R.A. (2006). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25(3):455-471. (Pubitemid 44354214)
10. Lin, H.Y., Moustakas, A., Knaus, P., Wells, R.G., Henis, Y.I., Lodish, H.F. (1995). The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J. Biol. Chem. 270(6):2747-2754.
11. Lin, Y.C., Chang, Y.M., Yu, J.M., Yen, J.H., Chang, J.G., Hu, C.J. (2005). Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180(2):305-309.
12. Loeys, B.L., Chen, J., Neptune, E.R., Judge, D.P., Podowski, M., Holm, T., Meyers, J., Leitch, C.C., Katsanis, N., Sharifi, N., Xu, F.L., Myers, L.A., Spevak, P.J., Cameron, D.E., De Backer, J., Hellemans, J., Chen, Y., Davis, E.C., Webb, C.L., Kress, W., Coucke, P., Rifkin, D.B., De Paepe, A.M., Dietz, H.C. (2005). A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37(3):275-281. (Pubitemid 41716254)
13. Mizuguchi, T., Collod-Beroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T., Allard, D., Varret, M., Claustres, M., Morisaki, H., Ihara, M., Kinoshita, A., Yoshiura, K., Junien, C., Kajii, T., Jondeau, G., Ohta, T., Kishino, T., Furukawa, Y., Nakamura, Y., Niikawa, N., Boileau, C., Matsumoto, N. (2004). Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 36(8):855-860.
14. Muengtaweepongsa, S., Singh, N.N., Cruz-Flores, S. (2010). Pontine warning syndrome: case series and review of literature. J. Stroke Cerebrovasc. Dis. 19(5):353-356.
15. Parsons, R., Myeroff, L.L., Liu, B., Willson, J.K., Markowitz, S.D., Kinzler, K.W., Vogelstein, B. (1995). Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55(23):5548-5550.
16. Pyzik, M., Piccirillo, C.A. (2006). The TGF-beta1/Foxp3 regulatory axis in immune self-tolerance: implications for health and disease. Inflamm. Allergy Drug Targets 5(3):167-177. (Pubitemid 44377802)
17. Rechtman, M.M., Nakaryakov, A., Shapira, K.E., Ehrlich, M., Henis, Y.I. (2009). Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors. J. Biol. Chem. 284(12):7843-7852.
18. Reuter, B., Bugert, P., Stroick, M., Bukow, S., Griebe, M., Hennerici, M.G., Fatar, M. (2009). TIMP-2 gene polymorphism is associated with intracerebral hemorrhage. Cerebrovasc. Dis. 28(6):558-563.
19. Rezaii, A.A., Hoseinipanah, S.M., Hajilooi, M., Rafiei, A.R., Shikh, N., Haidari, M. (2009). Interleukin-1 receptor antagonist gene polymorphism and susceptibility to ischemic stroke. Immunol. Invest. 38(3-4):220-230.
20. Shi, K.L., He, B., Wang, J.J., Zou, L.P. (2009). Role of TNF-alpha gene variation in idiopathic childhood ischemic stroke: a case-control study. J. Child. Neurol. 24(1):25-29.
21. Shiber, J.R., Fontane, E., Adewale, A. (2010). Stroke registry: hemorrhagic vs ischemic strokes. Am. J. Emerg. Med. 28(3):331-333.
22. Singh, K.K., Rommel, K., Mishra, A., Karck, M., Haverich, A., Schmidtke, J., Arslan- Kirchner, M. (2006). TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum. Mutat. 27(8):770-777. (Pubitemid 44205070)
23. Tanaka, S., Mori, M., Mafune, K., Ohno, S., Sugimachi, K. (2000). A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Br. J. Cancer 82(9):1557-1660.
24. Tseng, Z.H., Vittinghoff, E., Musone, S.L., Lin, F., Whiteman, D., Pawlikowska, L., Kwok, P.Y., Olgin, J.E., Aouizerat, B.E. (2009). Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm. 6(12):1745-1750.
25. Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Crews, L., Tremblay, P., Mathews, P., Mucke, L., Masliah, E., Wyss-Coray, T. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimers pathology. J. Clin. Invest. 116(11):3060-3069. (Pubitemid 44684491)
26. Van Asch, C.J., Luitse, M.J., Rinkel, G.J., van der Tweel, I., Algra, A., Klijn, C.J. (2010). Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 9:167-176.
27. Wang, J.J., Jiang, L.Q., He, B., Shi, K.L., Li, J.W., Zou, L.P. (2009). The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population. Int. J. Immunogenet. 36(2):113-118.
28. Yoshida, T., Kato, K., Yokoi, K., Oguri, M., Watanabe, S., Metoki, N., Yoshida, H., Satoh, K., Aoyagi, Y., Nishigaki, Y., Nozawa, Y., Yamada, Y. (2009). Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. Int. J. Mol. Med. 23(6):785-792.
29. Yun, J.Y., Uhm, Y.K., Kim, H.J., Lim, S.H., Chung, J.H., Shin,M.K., Yim, S.V., Lee, M.H. (2010). Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population. Int. J. Immunogenet. 37(4):289-291.